A Single Ascending Dose Study (SAD) In Healthy Subjects To Evaluate The Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile Of Tecarfarin.
Phase of Trial: Phase I
Latest Information Update: 09 Feb 2017
At a glance
- Drugs Tecarfarin (Primary)
- Indications Thromboembolism
- Focus Pharmacodynamics; Pharmacokinetics
- 09 Feb 2017 Results published in the Thrombosis and Haemostasis.
- 31 Dec 2016 New trial record